My lab?s contributions have helped bring lung biology to the forefront of stem cell biology. Our major focus has been to develop tools to characterize progenitor cells in the adult lung and in lung cancer; I now aim to develop this expertise for applications in lung diseases. We created three-dimensional co-culture organoid systems that have begun to define cell-cell crosstalk between epithelial progenitors and other supporting cell types in the lung. We can now model the formation of airway- and alveolar-like structures from lung progenitor cells, and we have a platform to understand differentiation control at the molecular level. This research program seeks to build on our advances and to further develop lung organoids to interrogate the molecular underpinnings of cell-cell interactions between epithelial progenitor cells and their environment in the adult lung homeostasis and in diseased lung. We will determine the signals through which epithelial progenitors are regulated by mesenchymal cells and endothelial cells during lung injury response and repair. Cells from mouse models of lung disease will be used for single cell RNA-sequencing and in organoid systems to identify cell autonomous and paracrine mechanisms that can be used for therapeutic intervention. We will refine our techniques for use with human lung cells. We will create a lung progenitor cell transplantation assay, a critical need in the lung community for the study of progenitors and for regenerative medicine. While other groups are focused on cataloging lung cell types, our strategies will provide essential tools to interrogate the biological functions of diverse lung cells. Collectively, these new approaches will allow us to continue to build and utilize transformative methods to probe numerous aspects of the biology of normal lung and lung disease.

Public Health Relevance

These studies will allow development of a transplantation method, an important tool to study the role of progenitor cells in repairing damaged lung tissue. We will also discover factors that can stimulate airway and alveolar repair. Our proposed studies will provide new ways to understand and treat lung disease.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Unknown (R35)
Project #
5R35HL150876-02
Application #
10124213
Study Section
Special Emphasis Panel (ZHL1)
Program Officer
Lin, Sara
Project Start
2020-03-15
Project End
2027-01-30
Budget Start
2021-01-31
Budget End
2022-01-30
Support Year
2
Fiscal Year
2021
Total Cost
Indirect Cost
Name
Boston Children's Hospital
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02115